Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. 2006. FDA drug prescribing warnings: Is the black box half empty or half full? Pharmacoepidemiology and Drug Safety 15(6):369–386.
Wakefield DS, Wakefield BJ, Borders T, Uden-Holman T, Blegen M, Vaughn T. 1999. Understanding and comparing differences in reported medication administration error rates. American Journal of Medical Quality 14(2):73–80.
Walls CA, Rhodes KV, Kennedy JJ. 2002. The emergency department as usual source of medical care: Estimates from the 1998 National Health Interview Survey. Academic Emergency Medicine 9(11):1140–1145.
Walters PG. 1992. FDA’s new drug evaluation process: A general overview. Journal of Public Health and Dentistry 52:333–337.
Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. 2000. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thrombosis and Haemostasis 83(5): 661–665.
Wazana A. 2000. Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association 283(3):373–380.
Weatherby LB, Walker AM, Fife D, Vervaet P, Klausner MA. 2001. Contraindicated medications dispensed with cisapride: Temporal trends in relation to the sending of “Dear doctor” letters. Pharmacoepidemiology and Drug Safety 10:210–218.
Weatherby LB, Nordstrom BL, Fife D, Walker AM. 2002. The impact of wording in “Dear doctor” letters and in black box labels. Clinical Pharmacology and Therapeutics 72(6):735–742.
Wilkes MS, Bell RA, Kravitz RL. 2000. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs 19:110–128.
Woods A, Johnson SD. 2002. Executive summary: Toward a taxonomy of nursing practice errors. Nursing Management 33(10):45–48.